512
Views
19
CrossRef citations to date
0
Altmetric
Clinical Research

Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab’)2 versus Fab antivenom trial

, , &
Pages 109-114 | Received 03 Aug 2016, Accepted 15 Oct 2016, Published online: 03 Nov 2016

References

  • Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347–356.
  • Gutierrez JM, Escalante T, Rucavado A. Experimental pathophysiology of systemic alterations induced by Bothrops asper snake venom. Toxicon. 2009;54:976–987.
  • McCleary RJ, Kini RM. Snake bites and hemostasis/thrombosis. Thromb Res. 2013;132:642–646.
  • Ali AJ, Horwitz DA, Mullins ME. Lack of coagulopathy after copperhead snakebites. Ann Emerg Med. 2015;65:404–409.
  • Walker JP, Morrison RL. Current management of copperhead snakebite. J Am Coll Surgeons. 2011;212:470–474.
  • Bowers RC, Kwinter D, Shaw C, et al. The utility of serial coagulation profiles in management of Agkistrodon contortrix envenomation. Ann Emerg Med. 2012;60:S124–S1S5.
  • Evans C, Drake WG, Diskina M, et al. Hematologic abnormalities and bleeding in copperhead snakebite. Wild Environ Med. 2014;25:116–119.
  • Gale SC, Peters JA, Allen L, et al. FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction? J Venom Anim Toxins Incl Trop Dis. 2016;22:2.
  • Kopec KT, Yen M, Bitner M, et al. Marked hypofibrinogenemia and gastrointestinal bleeding after copperhead (Agkistrodon contortrix) envenomation. Wild Environ Med. 2015;26:488–490.
  • Thorson A, Lavonas EJ, Rouse AM, et al. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003;41:29–35.
  • Tanen DA, Ruha AM, Graeme KA, et al. Rattlesnake envenomations: unusual case presentations. Arch Intern Med. 2001;161:474–479.
  • Levine M, Ruha AM, Padilla-Jones A, et al. Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications. Acad Emerg Med. 2014;21:301–307.
  • Ruha AM, Curry SC, Albrecht C, et al. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom. Toxicon. 2011;57:53–59.
  • Lavonas EJ, Khatri V, Daugherty C, et al. Medically significant late bleeding after treated crotaline envenomation: a systematic review. Ann Emerg Med. 2014;63:71–78.
  • Bush SP, Ruha AM, Seifert SA, et al. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol. 2015;53:37–45.
  • Liu G, Liang KY. Sample size calculations for studies with correlated observations. Biometrics. 1997;53:937–947.
  • Diggle PJ, Heagerty PJ, Liang KY, et al Analysis of longitudinal data. 2nd ed. Oxford: Statistical Science Series; 2002.
  • Worster A, Haines T. Advanced statistics: understanding medical record review (MRR) studies. Acad Emerg Med. 2004;11:187–192.
  • Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996;27:305–308.
  • Berbarta VS, Morrissey R, Mirkin D. Antivenom use for copperhead envenomations. J Am Coll Surgeons. 2011;213:692–693.
  • Janes DN Jr., Bush SP, Kolluru GR. Large snake size suggests increased snakebite severity in patients bitten by rattlesnakes in Southern California. Wilderness Environ Med. 2010;21:120–126.
  • Yin S, Kokko J, Lavonas E, et al. Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients. Acad Emerg Med. 2011;18:46–52.
  • Seifert SA, Ronald IK, Martin N. Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snakebite. Clin Toxicol. 2011;49:324–329.
  • Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2.
  • Kanaan NC, Ray J, Stewart M, et al. Wilderness Medical Society practice guidelines for the treatment of pit viper envenomations in the United States and Canada. Wild Environ Med. 2015;26:472–487.
  • Lavonas EJ. Coagulopathy: the most important thing we still don't know about snakebite. West J Emerg Med. 2012;13:75–76.
  • Dart RC, Hurlbut KM, Garcia R, et al. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996;27:321–326.
  • Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39.
  • Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030–2036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.